Next Article in Journal
Marine Biotoxins in Crustaceans and Fish—A Review
Previous Article in Journal
Impact of Regulated and Non-Regulated Food-Associated Mycotoxins on the Viability and Proliferation of Enteric Glial Cells
Previous Article in Special Issue
Inhibition Effects of Infrared Radiation Prior to Cold Storage Against Alternaria alternata on Yellow Peach (Amygdalus persica)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Heterologous Expression, Enzymatic Characterization, and Ameliorative Effects of a Deoxynivalenol (DON)-Degrading Enzyme in a DON-Induced Mouse Model

1
School of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China
2
College of Animal Science and Technology, Henan Agricultural University, Zhengzhou 450046, China
*
Authors to whom correspondence should be addressed.
Toxins 2025, 17(12), 588; https://doi.org/10.3390/toxins17120588
Submission received: 2 October 2025 / Revised: 1 November 2025 / Accepted: 2 December 2025 / Published: 9 December 2025

Abstract

Deoxynivalenol (DON), a mycotoxin produced by Fusarium species, severely contaminates grains and feed, posing a continuous threat to human and livestock health. In this study, the DON-degrading enzyme (DDE) gene from Devosia sp. JA3 was heterologously expressed in Escherichia coli. Enzyme kinetics revealed that DDE exhibited optimal activity at 37 °C and pH 7.0, with a Km of 0.32 mM and a Vmax of 563.3 nmol/(min·mg). Under optimized conditions, DDE efficiently oxidized DON to 3-keto-DON, achieving a degradation rate of 82.51% within 12 h. Further investigation in C57BL/6J mice showed that oral administration of 2 mg/kg DON significantly reduced antioxidant capacity, caused liver damage, impaired intestinal barrier function, induced intestinal inflammation and apoptosis, and disrupted the gut microbiota. DDE treatment effectively alleviated these DON-induced effects by restoring antioxidant capacity, ameliorating liver injury, downregulating pro-inflammatory and apoptotic genes, upregulating barrier-related genes, and restoring the gut microbiota balance, thereby protecting intestinal health. These findings demonstrate DDE’s excellent DON-degrading capacity and biosafety, providing new technical evidence for DON detoxification applications.
Keywords: deoxynivalenol (DON); DON-degrading enzyme; heterologous expression; enzyme kinetics; gut microbiota deoxynivalenol (DON); DON-degrading enzyme; heterologous expression; enzyme kinetics; gut microbiota

Share and Cite

MDPI and ACS Style

Zhou, H.; Xu, B.; Peng, Y.; Mao, J.; Zhang, X.; Guo, Y.; Zhang, Y. Heterologous Expression, Enzymatic Characterization, and Ameliorative Effects of a Deoxynivalenol (DON)-Degrading Enzyme in a DON-Induced Mouse Model. Toxins 2025, 17, 588. https://doi.org/10.3390/toxins17120588

AMA Style

Zhou H, Xu B, Peng Y, Mao J, Zhang X, Guo Y, Zhang Y. Heterologous Expression, Enzymatic Characterization, and Ameliorative Effects of a Deoxynivalenol (DON)-Degrading Enzyme in a DON-Induced Mouse Model. Toxins. 2025; 17(12):588. https://doi.org/10.3390/toxins17120588

Chicago/Turabian Style

Zhou, Haorui, Bingtao Xu, Yuqing Peng, Jiahao Mao, Xuelei Zhang, Yongpeng Guo, and Yong Zhang. 2025. "Heterologous Expression, Enzymatic Characterization, and Ameliorative Effects of a Deoxynivalenol (DON)-Degrading Enzyme in a DON-Induced Mouse Model" Toxins 17, no. 12: 588. https://doi.org/10.3390/toxins17120588

APA Style

Zhou, H., Xu, B., Peng, Y., Mao, J., Zhang, X., Guo, Y., & Zhang, Y. (2025). Heterologous Expression, Enzymatic Characterization, and Ameliorative Effects of a Deoxynivalenol (DON)-Degrading Enzyme in a DON-Induced Mouse Model. Toxins, 17(12), 588. https://doi.org/10.3390/toxins17120588

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop